ANOFE 10000 PFS IU FOR EFFECTIVE ANEMIA TREATMENT AND SUPPORTIVE CARE

ANFOE 10000 PFS is an injectable prescription medication containing recombinant human erythropoietin alfa. It is used to treat anemia by stimulating the bone marrow to produce more healthy red blood cells. It needs to be stored in a fridge but used at room temperature. It is prescribed to treat anemia caused by chronic kidney disease or chemotherapy.

WHAT IS AN OFE 10000 IU INJECTION PFS?

ANOFE 10000 IU PFS is an erythropoiesis-stimulating agent (ESA) classified therapeutically as a hematopoietic agent. Its active ingredient is recombinant human erythropoietin alfa, which stimulates the bone marrow to produce red blood cells.

Key classification:

  • Pharmacological class: Erythropoietin / erythropoiesis-stimulating agent (ESA)
  • Therapeutic class: Hematopoietic Agent/Anti-anemic
  • Active ingredient: recombinant human erythropoietin alfa (10000 IU)

WHAT ARE THE MEDICAL USES OF ANOFE 10000 IU INJECTION?

Medical uses of ANOFE 10000 IU injection are the following:

1) Anemia associated with chronic kidney disease (CKD)

ANOFE 10000 IU prefilled syringe (PFS) contains recombinant human erythropoietin alfa. It stimulates the bone marrow to produce red blood cells. It is primarily prescribed to treat anemia caused by chronic kidney disease (CKD)—both in dialysis and non-dialysis patients—by alleviating fatigue and tissue oxygen deprivation.

2) Chemotherapy-induced anemia

ANOF 10000IU is an injectable hormone that treats chemotherapy-induced anemia by stimulating the bone marrow to produce red blood cells. It helps correct low blood counts, alleviates fatigue, and reduces the need for red blood cell transfusion.

It works in the following ways:

Supportive care for cancer patients

ANOF 10000 IU is an erythropoiesis-stimulating agent (ESA) used as supportive care to treat chemotherapy-induced anemia in cancer patients. It stimulates the bone marrow to produce red blood cells, reducing the need for blood transfusion and alleviating fatigue. Its purpose is to manage low RBC caused by cancer chemotherapy.

Reducing the need for blood transfusions

By elevating and maintaining hemoglobin levels, ANOF 10000IU is highly effective at preventing severe anemia, thereby reducing or eliminating the need for RBC transfusions in patients with chronic kidney disease, those undergoing chemotherapy, or those preparing for major surgery.

3) Anemia related to certain medical conditions

ANOFE 10000IU is an ESA that works by mimicking the natural hormone erythropoietin to stimulate the bone marrow to produce RBCs. It is primarily used to correct anemia and reduce the need for blood transfusions.

Treatment of anemia due to low erythropoietin levels

ANOFE 10000IU injection—containing recombinant human erythropoietin alfa—is primarily used to treat anemia, mimicking the natural hormone that stimulates the bone marrow to produce RBC. It specifically addresses anemia caused by chronic kidney disease (CKD) and cancer chemotherapy. It works by supplementing the body’s depleted erythropoietin in the bone marrow to restart and accelerate the creation of healthy red blood cells.

Management of certain chronic diseases

ANOFE 10000IU is prescribed under strict medical supervision to manage anemia related to

A) Chronic kidney disease (CKD): Patients with failing kidneys often do not produce enough natural erythropoietin, leading to severe anemia. ANOF helps treat this and is used in both adult and pediatric patients.

B) Cancer chemotherapyCOMPREHENSIVE GUIDE TO CHEMOTHERAPY AND CANCER CARE:  Some chemotherapy drugs kill RBCs along with cancer cells. ANOFE 10000IU is prescribed to increase hemoglobin levels, relieve severe fatigue, and reduce the need for blood transfusions.

C) HIV treatment complications: It is utilized to treat anemia caused by specific antiviral medications that can suppress bone marrow function.

4) Post-surgical use

Increases RBC count before major surgery

ANOFE 10000IU is used pre-surgery to stimulate the bone marrow to produce RBCs. This practice increases preoperative hemoglobin levels, thereby reducing or entirely eliminating the need for allogenic donor blood transfusions during or after major surgeries.

Minimizing transfusion requirement

ANOFE10000IU acts like a natural hormone, erythropoietin, correcting the low hemoglobin counts and improving the body’s oxygen-carrying capacity. For patients undergoing major elective, non-cardiac, non-vascular surgeries, it is often given preoperatively to build up red blood cell reserves, lowering the risk of needing allogeneic blood transfusions.

HOW DOES THE ANOFE 10000IU INJECTION WORK?

Epotin alpha is a recombinant form of the natural human hormone erythropoietin. it stimulates erythropoiesis by binding to and activating erythropoietin receptors on progenitor cells in the bone marrow, preventing their cell death and promoting their division and maturation into red blood cells .

It works in the following ways:

• Stimulating bone marrow to produce red blood cells

The target ingredient, Recombinant Human Erythropoietin Alpha, binds to specific receptors on progenitor cells in the bone marrow. This triggers a signaling cascade that forces the bone marrow stem cells to mature into healthy red blood cells and reticulocytes. By increasing the number of circulating red blood cells, it corrects anemia, raises the hemoglobin, and improves the oxygen-carrying capacity to reduce fatigue.

Increasing hemoglobin levels

ANOFE 10000IU mimics the body’s natural hormone to stimulate the bone marrow into producing more RBC, which reverses the effects of anemia caused by chronic kidney disease or chemotherapy. The exact speed at which hemoglobin increases varies by patient. It typically takes several weeks to observe a significant, steady rise in red blood cell count.

• Improving oxygen delivery throughout the body

By boosting red blood cell levels, it improves oxygen delivery to tissues, reducing fatigue and weakness. Red blood cells are responsible for carrying oxygen from the lungs to the rest of the body. When a person is anemic, a shortage of these cells leaves tissues deprived of oxygen.

CONCLUSION

ANOFE 10000 IU is a recombinant human erythropoietin used to treat anemia from chronic kidney disease, chemotherapy, or HIV treatment. By stimulating the bone marrow to produce red blood cells, it corrects hemoglobin levels and reduces the need for transfusions, ultimately improving vitality and combating fatigue.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS ANOF INJECTION USED FOR?

ANOFE 10000IU injection is a synthetic form of the hormone erythropoietin. It stimulates the bone marrow to produce more red blood cells. It is primarily used to treat anemia caused by chronic kidney diseases, cancer chemotherapy, or HIV treatments.

QUESTION: HOW DOES EPOTIN ALFA WORK?

Epotin Alfa is a man-made version of the natural hormone EPO, which is produced by healthy kidneys. It is used to treat anemia caused by chronic kidney disease, cancer chemotherapy, or HIV treatments by stimulating the bone marrow to produce more red blood cells.

REFERENCES:

1)https://www.apollopharmacy.in/medicine/anfoe-10000iu-injection-1-0ml?srsltid=AfmBOooLV1APInQ9WTiia2frcStoHYrJq10hkaWG59-pT5H96IDtbbeh

2https://www.truemeds.in/medicine/anfoe-10000-iu-injection-1-tm-inon2-000381

Leave a Reply

Your email address will not be published. Required fields are marked *

Add to cart